Yasuhiro Fujsawa

83PUBLICATIONS
95CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (83)

|Jan 08, 2026
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol.

Taku Fujimura, Koji Yoshino, Hiroshi Kato

|Jan 07, 2026
Genomic and transcriptomic analyses of melanoma in Japanese patients reveal candidate biomarkers for immune checkpoint inhibitor responders.

T Kimura, N Tanaka, T Maekawa

|Dec 31, 2025
Real-World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese Patients.

Azusa Miyashita, Satoshi Fukushima, Koji Yoshino

|Nov 29, 2025
Tear Fluid Indirect Immunofluorescence for Assessing Disease Activity in Ocular Mucous Membrane Pemphigoid: First Report of a New Method for Monitoring Disease Progression.

Nobushige Kohri, Kazuki Yatsuzuka, Norito Ishii

|Oct 16, 2025
Novel Therapeutic Approaches for Cutaneous Angiosarcoma, Particularly Focusing on Immune Checkpoint Inhibitors.

Yasuhiro Fujisawa

|Jul 19, 2025
Secondary Publication of Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Angiosarcoma 2025.

Yasuhiro Fujisawa, Yasuo Yoshioka, Koji Yoshino

Pageof 14

Frequent Collaborators

39 joint publications

Yoshiyuki Nakamura

37 joint publications

Naoko Okiyama

26 joint publications

Rei Watanabe

16 joint publications

Yosuke Ishitsuka